Design of new antihypertensive drugs: potent and specific inhibitors of angiotensin-converting enzyme.
D000959:Antihypertensive Agents / Q000494:pharmacology*; D001665:Binding Sites; D001667:Binding, Competitive; D002268:Carboxypeptidases / Q000494:pharmacology; D004791:Enzyme Inhibitors; D006973:Hypertension / Q000201:enzymology*; D008954:Models, Biological; D010455:Peptides / Q000494:pharmacology; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D010455:Peptides; D013438:Sulfhydryl Compounds; D002268:Carboxypeptidases; D007703:Peptidyl-Dipeptidase A